Antiprogrammed Cell Death‐1 Immunotherapy‐Related Secondary Sclerosing Cholangitis
Kohei Ogawa, Kenya Kamimura, Shuji Terai – 23 July 2018
Kohei Ogawa, Kenya Kamimura, Shuji Terai – 23 July 2018
Riccardo Superina – 23 July 2018
Juan P. Arab, Marco Arrese – 23 July 2018
Chung Mau Lo – 23 July 2018
Maximilian A. Ardelt, Thomas Fröhlich, Emanuele Martini, Martin Müller, Veronika Kanitz, Carina Atzberger, Petra Cantonati, Martina Meßner, Laura Posselt, Thorsten Lehr, Jan‐Georg Wojtyniak, Melanie Ulrich, Georg J. Arnold, Lars König, Dario Parazzoli, Stefan Zahler, Simon Rothenfußer, Doris Mayr, Alexander Gerbes, Giorgio Scita, Angelika M. Vollmar, Johanna Pachmayr – 23 July 2018 – Therapeutic options for patients with advanced‐stage hepatocellular carcinoma (HCC) are very limited.
David A. Brenner – 23 July 2018
Ariel W. Aday, Jacqueline G. O’Leary – 20 July 2018
Hong Wang, Chris Zhiyi Zhang, Shi‐Xun Lu, Mei‐Fang Zhang, Li‐Li Liu, Rong‐Zhen Luo, Xia Yang, Chun‐Hua Wang, Shi‐Lu Chen, Yang‐Fan He, Dan Xie, Rui‐Hua Xu, Jing‐Ping Yun – 20 July 2018 – Deregulation of alternative splicing contributes to the malignant progression of cancer. Little is known about the significant alternative splicing events in hepatocellular carcinoma (HCC). High‐throughput sequencing revealed that coiled‐coil domain containing 50 (CCDC50) pre‐mRNA is aberrantly spliced in 50% of our HCC cases.
Kosh Agarwal, Sarah E. Brown – 20 July 2018